A publicly held, multinational investment company plans to acquire a St. Louis-area real estate private equity firm.

23andMe Holding Co. will be sold to TTAM Research Institute, a genetics-led healthcare company based in California and led by 23andMe co-founder and former CEO Anne Wojcicki.

A high-profile biotech venture's attempt to streamline its real estate portfolio through bankruptcy court is facing ...